UBS Group Analysts Give Hannover Re (FRA:HNR1) a €135.00 Price Target

UBS Group set a €135.00 ($156.98) price objective on Hannover Re (FRA:HNR1) in a report released on Thursday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other analysts have also commented on HNR1. Goldman Sachs Group set a €120.00 ($139.53) price target on shares of Hannover Re and gave the company a neutral rating in a research report on Tuesday, April 23rd. Independent Research set a €130.00 ($151.16) price target on shares of Hannover Re and gave the company a neutral rating in a research report on Friday, March 8th. Royal Bank of Canada set a €130.00 ($151.16) price target on shares of Hannover Re and gave the company a neutral rating in a research report on Tuesday, May 7th. Deutsche Bank set a €116.00 ($134.88) price target on shares of Hannover Re and gave the company a neutral rating in a research report on Friday, April 12th. Finally, DZ Bank restated a neutral rating on shares of Hannover Re in a research report on Tuesday, May 7th. Five research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. The stock presently has a consensus rating of Hold and an average target price of €119.92 ($139.45).

Shares of HNR1 stock opened at €141.70 ($164.77) on Thursday. Hannover Re has a twelve month low of €94.75 ($110.17) and a twelve month high of €116.37 ($135.31).

About Hannover Re

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

Read More: How does equity income fit into an investing strategy?

Analyst Recommendations for Hannover Re (FRA:HNR1)

Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.